病理完整反应的额外危险
Orit Kaidar-Person1, Philip Poortmans2, Icro Meattini3
1Breast Cancer Radiation Therapy Unit, at Sheba Medical Center, Ramat Gan, Israel; Tel Aviv Medical School, Tel Aviv University, Israel.
概括
病理完整反应 (pCR) 预测了侵袭性早期乳腺癌的结果. 本综述探讨了PCR测定挑战以及PCR后个性化放射治疗的数据需求.
科学领域:
- 在瘤学瘤学.
- 放射疗法是一种放射治疗.
- 乳腺癌研究研究 乳腺癌研究
背景情况:
- 病理完整反应 (pCR) 是接受新辅助全身治疗的侵袭性早期乳腺癌患者长期结果的重要预测因素.
- 准确评估pCR对于治疗评估和患者管理至关重要.
研究的目的:
- 批判性地评估与确定乳腺癌病理完整反应 (pCR) 相关的方法和挑战.
- 确定为调整乳腺癌患者实现pCR的放射治疗策略所需的基本数据.
主要方法:
- 关于乳腺癌中pCR评估的当前文献的综述.
- 对临床试验数据和与新辅助疗法和放射瘤学相关的指导方针的分析.
- 讨论PCR对治疗降级和强化的影响.
主要成果:
- 在不同研究和机构的pCR定义和病理评估中存在差异.
- 目前的数据不足以确定所有患者子组的PCR后放射治疗决策.
- 在某些情况下,实现pCR可能需要放缓放射治疗,但需要进一步调查.
结论:
- 需要对PCR评估进行标准化,以提高研究结果的可比性和可靠性.
- 需要进行进一步的研究,以确定在实现pCR后定制乳腺癌放射治疗的强有力的标准.
- 结合pCR状态的个性化治疗策略对于优化早期乳腺癌的结果至关重要.
相关概念视频
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K


